Benoît Tessoulin
29PUBLICATIONS
113CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (29)
Sort by Publication Date:
|Feb 19, 2026
CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.Candice Madiot, Céline Bellanger, Christelle Dousset
|Jan 16, 2026
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.Krish Patel, Julie M Vose, Sunita D Nasta
|Nov 03, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc
|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.Federico Erbella, Emmanuel Bachy, Guillaume Cartron
|Sep 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group.Marion Aymard, Morgane Cheminant, Roch Houot
|Aug 22, 2025
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study.Nirav N Shah, Pier Luigi Zinzani, Michael Wang
Pageof 5
Frequent Collaborators
7 joint publications
Franck Morschhauser
6 joint publications
Yannick Le Bris
6 joint publications
Cyrille Touzeau
6 joint publications
Steven Le Gouill
5 joint publications
Ghandi Damaj
4 joint publications
Patrice Chevallier
4 joint publications
Philippe Moreau
4 joint publications
David Chiron
4 joint publications
Thierry Guillaume
4 joint publications
Maxime Jullien
